Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03578302 · ClinicalTrials.gov registry record

The Heidelberg Engineering BI US Evaluation Study

A clinical trial, sponsored by Heidelberg Engineering.

Completed
Registry status
39
Enrollment target

NCT03578302 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 39 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03578302 has completed, sponsored by Heidelberg Engineering.

COMPLETED
Registry status
39 participants
Enrollment target

Study Summary

Evaluation of defined parameters measured in pathological and non-pathological eyes with the Heidelberg BI

Interventions

  • DEVICE BI Anterior Segment Mode
  • DEVICE BI Anterior Segment and IOL Biometry Mode

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2018-05-22
Est. Completion 2018-12-03

Sponsor

Heidelberg Engineering

16 total trials

What the Registry Record Tells You About NCT03578302

The ClinicalTrials.gov registry entry for NCT03578302 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heidelberg Engineering, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which BI Anterior Segment Mode is the first listed.

NCT03578302 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03578302 about?

NCT03578302 is a clinical study titled "The Heidelberg Engineering BI US Evaluation Study". Evaluation of defined parameters measured in pathological and non-pathological eyes with the Heidelberg BI

What is the current status of trial NCT03578302?

This trial is currently completed. The enrollment target is 39 participants. The study started on 2018-05-22. Estimated completion is 2018-12-03.

What interventions are being tested in trial NCT03578302?

The interventions under investigation include: BI Anterior Segment Mode (DEVICE), BI Anterior Segment and IOL Biometry Mode (DEVICE).

Who is sponsoring clinical trial NCT03578302?

This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.